Kiverdi Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 14

Employees

  • Latest Deal Type
  • Debt - PPP

  • Latest Deal Amount
  • $348K

  • Investors
  • 9

Kiverdi General Information

Description

Developer of a bioprocessing technology designed to transform carbon dioxide and other gases into valuable, bio-based products. The company's technology makes a protein directly from carbon dioxide which contains all the essential amino acids that have a profile similar to an animal protein, enabling clients to meet the growing need for food.

Contact Information

Website
www.kiverdi.com
Formerly Known As
Sequesco
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 1252 Quarry Lane
  • Suite B
  • Pleasanton, CA 94566
  • United States
+1 (415)
Primary Industry
Biotechnology
Other Industries
Environmental Services (B2B)
Corporate Office
  • 1252 Quarry Lane
  • Suite B
  • Pleasanton, CA 94566
  • United States
+1 (415)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kiverdi Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Debt - PPP 31-Jan-2021 $348K Completed Generating Revenue
8. Accelerator/Incubator 01-Jan-2021 Completed Generating Revenue
7. Later Stage VC (Series A1) 17-Dec-2020 Completed Generating Revenue
6. Debt - PPP 01-May-2020 Completed Generating Revenue
5. Grant 31-Dec-2018 Completed Generating Revenue
4. Seed Round Completed Generating Revenue
3. Grant 31-Dec-2015 Completed Generating Revenue
2. Seed Round 03-Feb-2015 $1.5M $1.5M Completed Generating Revenue
1. Grant 05-Sep-2012 $747K Completed Startup
To view Kiverdi’s complete valuation and funding history, request access »

Kiverdi Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A-1
Series A
To view Kiverdi’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Kiverdi Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a bioprocessing technology designed to transform carbon dioxide and other gases into valuable, bio-based pr
Biotechnology
Pleasanton, CA
14 As of 2024

Paris, France
 

Roskilde, Denmark
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kiverdi Competitors (3)

One of Kiverdi’s 3 competitors is Arbiom, a Venture Capital-Backed company based in Paris, France.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Arbiom Venture Capital-Backed Paris, France
Unibio Venture Capital-Backed Roskilde, Denmark
Calysta Venture Capital-Backed San Mateo, CA
You’re viewing 3 of 3 competitors. Get the full list »

Kiverdi Patents

Kiverdi Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4363553-A1 Reduction of endotoxins in bacterial protein preparations Pending 30-Jun-2021
US-20240277005-A1 Reduction of endotoxins in bacterial protein preparations Pending 30-Jun-2021
EP-4341362-A1 High productivity bioprocesses for the massively scalable and ultra-high throughput conversion of co2 into valuable products Pending 17-May-2021
US-20240254398-A1 High productivity bioprocesses for the massively scalable and ultra-high throughput conversion of co2 into valuable products Pending 17-May-2021
US-20250051650-A1 High productivity bioprocesses for the massively scalable and ultra-high throughput conversion of co2 into valuable products Pending 17-May-2021 C10G2/50
To view Kiverdi’s complete patent history, request access »

Kiverdi Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kiverdi Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
The Circulars Accelerator Accelerator/Incubator
Unreasonable Impact Impact Investing Minority
U.S. Department of Energy Government
Kapor Capital Venture Capital Minority
Angel (individual) Minority
You’re viewing 5 of 9 investors. Get the full list »

Kiverdi FAQs

  • When was Kiverdi founded?

    Kiverdi was founded in 2008.

  • Where is Kiverdi headquartered?

    Kiverdi is headquartered in Pleasanton, CA.

  • What is the size of Kiverdi?

    Kiverdi has 14 total employees.

  • What industry is Kiverdi in?

    Kiverdi’s primary industry is Biotechnology.

  • Is Kiverdi a private or public company?

    Kiverdi is a Private company.

  • What is Kiverdi’s current revenue?

    The current revenue for Kiverdi is .

  • How much funding has Kiverdi raised over time?

    Kiverdi has raised $7.5M.

  • Who are Kiverdi’s investors?

    The Circulars Accelerator, Unreasonable Impact, U.S. Department of Energy, Kapor Capital, and are 5 of 9 investors who have invested in Kiverdi.

  • Who are Kiverdi’s competitors?

    Arbiom, Unibio, and Calysta are competitors of Kiverdi.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »